与博特佐米布一起的化疗RaST抑制了多发性骨髓瘤复发
Anchal Ghai1,2, Alexander Zheleznyak1, Christopher Egbulefu1,2
1Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Theranostics
|October 3, 2025
概括
一种新的Chemo-RaST疗法,将放射性核素疗法与博特佐米布结合起来,有效地消除多发性骨髓瘤细胞,并通过诱导活性氧物种来预防复发.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有高复发率的致命血液癌症.
- 目前的治疗方法由于瘤异质性而难以持续缓解.
- 克隆适应和抵抗限制了MM的治疗疗效.
研究的目的:
- 评估Chemo-RaST的疗效,即博特佐米布和89Zr-daratumumab介导的放射性核素疗法 (RaST) 的组合,用于预防MM复发.
- 研究Chemo-RaST在产生细胞毒性活性氧物种 (ROS) 的协同效应.
- 评估Chemo-RaST作为MM临床可转化策略的潜力.
主要方法:
- 化学RaST在MM.1S-luc小鼠模型 (皮下和传播) 中进行了测试.
- 在RaST中,89Zr标记的达拉图穆马布针对MM细胞,并激活TiO2-Tf-TC纳米粒子用于ROS生产.
- 博尔特佐米布同时用于增强线粒体ROS,有效性通过BLI,PET和基因病理学进行评估.
主要成果:
- *在体外*,RaST显著降低了MM.1S-luc细胞的活力.
- 虽然RaST单独抑制了瘤的进展,但发生了复发.
- 化学RaST在60%的传播MM模型中实现了完整的瘤回归,并改善了无进展的生存率.
- 组织病理学证实了MM细胞的消除,并恢复了血液形成.
结论:
- 89Zr的标记剂量能够持续激活光敏剂,从而产生有针对性的ROS.
- 亚治疗性博特佐米布可以放大ROS并克服抗药性.
- 化学RaST是一种有前途的,临床可转化策略,用于预防MM复发和限制毒性.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
599
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
599
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
808
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
808
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


